Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway

Fig. 4

Zn(ASA)2 improves left-ventricular cardiac function. a Representative original pressure–volume loops registered during transient occlusion of the inferior vena cava. The slope of end-systolic pressure–volume relationship (red line) and end-diastolic pressure–volume relationship (EDPVR, green line); b the slope of end-diastolic pressure–volume relationship (EDPVR); and c left-ventricular end-diastolic pressure (LVEDP). Values are mean ± SEM, n = 6–10. *P < 0.05 vs ZL, #P < 0.05 vs ZDF, $P < 0.05 vs Zn(ASA)2. Zn(ASA) 2 indicates a zinc complex of acetylsalicylic acid, ZDF Zucker diabetic fatty rats, ZL Zucker lean

Back to article page